He Y - Search Results

1

Nonsteroidal selective androgen receptor modulators enhance female sexual motivation.

Jones A, Hwang DJ, Duke CB 3rd, He Y, Siddam A, Miller DD, Dalton JT. Jones A, et al. Among authors: he y. J Pharmacol Exp Ther. 2010 Aug;334(2):439-48. doi: 10.1124/jpet.110.168880. Epub 2010 May 5. J Pharmacol Exp Ther. 2010. PMID: 20444881 Free PMC article.

2

Synthesis and human beta-adrenoceptor activity of 1-(3,5-diiodo-4- methoxybenzyl)-1,2,3,4-tetrahydroisoquinolin-6-ol derivatives in vitro.

He Y, Nikulin VI, Vansal SS, Feller DR, Miller DD. He Y, et al. J Med Chem. 2000 Feb 24;43(4):591-8. doi: 10.1021/jm990463j. J Med Chem. 2000. PMID: 10691685

3

Novel nonsteroidal ligands with high binding affinity and potent functional activity for the androgen receptor.

He Y, Yin D, Perera M, Kirkovsky L, Stourman N, Li W, Dalton JT, Miller DD. He Y, et al. Eur J Med Chem. 2002 Aug;37(8):619-34. doi: 10.1016/s0223-5234(02)01335-1. Eur J Med Chem. 2002. PMID: 12161060

4

Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor.

Yin D, He Y, Perera MA, Hong SS, Marhefka C, Stourman N, Kirkovsky L, Miller DD, Dalton JT. Yin D, et al. Among authors: he y. Mol Pharmacol. 2003 Jan;63(1):211-23. doi: 10.1124/mol.63.1.211. Mol Pharmacol. 2003. PMID: 12488554

5

Pharmacology, pharmacokinetics, and metabolism of acetothiolutamide, a novel nonsteroidal agonist for the androgen receptor.

Yin D, Xu H, He Y, Kirkovsky LI, Miller DD, Dalton JT. Yin D, et al. Among authors: he y. J Pharmacol Exp Ther. 2003 Mar;304(3):1323-33. doi: 10.1124/jpet.102.040832. J Pharmacol Exp Ther. 2003. PMID: 12604713

6

Pharmacodynamics of selective androgen receptor modulators.

Yin D, Gao W, Kearbey JD, Xu H, Chung K, He Y, Marhefka CA, Veverka KA, Miller DD, Dalton JT. Yin D, et al. Among authors: he y. J Pharmacol Exp Ther. 2003 Mar;304(3):1334-40. doi: 10.1124/jpet.102.040840. J Pharmacol Exp Ther. 2003. PMID: 12604714

7

Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulators.

Marhefka CA, Gao W, Chung K, Kim J, He Y, Yin D, Bohl C, Dalton JT, Miller DD. Marhefka CA, et al. Among authors: he y. J Med Chem. 2004 Feb 12;47(4):993-8. doi: 10.1021/jm030336u. J Med Chem. 2004. PMID: 14761201 Free PMC article.

8

Recent and emerging anti-diabetes targets.

Mohler ML, He Y, Wu Z, Hwang DJ, Miller DD. Mohler ML, et al. Among authors: he y. Med Res Rev. 2009 Jan;29(1):125-95. doi: 10.1002/med.20142. Med Res Rev. 2009. PMID: 18855890 Review.

9

Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit.

Mohler ML, Bohl CE, Jones A, Coss CC, Narayanan R, He Y, Hwang DJ, Dalton JT, Miller DD. Mohler ML, et al. Among authors: he y. J Med Chem. 2009 Jun 25;52(12):3597-617. doi: 10.1021/jm900280m. J Med Chem. 2009. PMID: 19432422 Review. No abstract available.

10

Dissociated non-steroidal glucocorticoids: tuning out untoward effects.

Mohler ML, He Y, Wu Z, Hong SS, Miller DD. Mohler ML, et al. Among authors: he y. Expert Opin Ther Pat. 2007 Jan;17(1):37-58. doi: 10.1517/13543776.17.1.37. Expert Opin Ther Pat. 2007. PMID: 20144062

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36,662 results

Search Page